Literature DB >> 19060415

Investigation of the anti-obesity action of licorice flavonoid oil in diet-induced obese rats.

Hiroshi Kamisoyama1, Kazuhisa Honda, Yuji Tominaga, Shinichi Yokota, Shin Hasegawa.   

Abstract

Licorice flavonoid oil (LFO), which contains hydrophobic flavonoids from Glycyrrhiza glabra LINNE, is a new ingredient for functional foods. In this study, we investigated the anti-obesity action of LFO in diet-induced obese rats. The addition of 2% LFO in a high-fat diet significantly decreased the weight of abdominal adipose tissue and the levels of hepatic and plasma triglycerides. We found that the enzymatic activities of acetyl-CoA carboxylase and fatty acid synthase, the rate-limiting enzymes in the fatty acid synthetic pathway, were significantly decreased by LFO, whereas the enzymatic activity of acyl-CoA dehydrogenase, the rate-limiting enzyme in the fatty acid oxidative pathway, was significantly increased. All our findings suggest that the anti-obesity action of LFO is controlled by regulation of the rate-limiting enzymes in the fatty acid synthetic and oxidative pathways in the liver.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19060415     DOI: 10.1271/bbb.80469

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  19 in total

1.  Lipogenesis is decreased by grape seed proanthocyanidins according to liver proteomics of rats fed a high fat diet.

Authors:  Isabel Baiges; Johan Palmfeldt; Cinta Bladé; Niels Gregersen; Lluís Arola
Journal:  Mol Cell Proteomics       Date:  2010-03-23       Impact factor: 5.911

Review 2.  Natural products: a safest approach for obesity.

Authors:  Neeru Vasudeva; Neerja Yadav; Surendra Kumar Sharma
Journal:  Chin J Integr Med       Date:  2012-07-22       Impact factor: 1.978

3.  cis-9,trans-11,cis-15 and cis-9,trans-13,cis-15 CLNA mixture activates PPARα in HEK293 and reduces triacylglycerols in 3T3-L1 cells.

Authors:  Jonatan Miranda; Arrate Lasa; Alfredo Fernández-Quintela; Cristina García-Marzo; Josune Ayo; Renaud Dentin; María P Portillo
Journal:  Lipids       Date:  2011-10-09       Impact factor: 1.880

Review 4.  Metabolic enzymes dysregulation in heart failure: the prospective therapy.

Authors:  Priyanka Parihar; Mordhwaj Singh Parihar
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

5.  AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity.

Authors:  Joo-Won Lee; Sung Sik Choe; Hagoon Jang; Jiyeong Kim; Hyun Woo Jeong; Hyunsun Jo; Kyeong-Hoon Jeong; Surendar Tadi; Myoung Gyu Park; Tae Hwan Kwak; Jin Man Kim; Dong-Hoon Hyun; Jae Bum Kim
Journal:  J Lipid Res       Date:  2012-04-09       Impact factor: 5.922

Review 6.  Flavonoids are promising safe therapy against COVID-19.

Authors:  Moza Mohamed Alzaabi; Rania Hamdy; Naglaa S Ashmawy; Alshaimaa M Hamoda; Fatemah Alkhayat; Neda Naser Khademi; Sara Mahmoud Abo Al Joud; Ali A El-Keblawy; Sameh S M Soliman
Journal:  Phytochem Rev       Date:  2021-05-22       Impact factor: 7.741

7.  A dual investigation of the effect of dietary supplementation with licorice flavonoid oil on anthropometric and biochemical markers of health and adiposity.

Authors:  Zach W Bell; Robert E Canale; Richard J Bloomer
Journal:  Lipids Health Dis       Date:  2011-02-10       Impact factor: 3.876

8.  Homology modelling of CB1 receptor and selection of potential inhibitor against Obesity.

Authors:  Mahesh Shrinivasan; Sinosh Skariyachan; Vaka Aparna; Vinod Rama Kolte
Journal:  Bioinformation       Date:  2012-06-16

9.  Assessment of Antiobesity Potential of Achyranthes aspera Linn. Seed.

Authors:  Neerja Rani; Surendra Kumar Sharma; Neeru Vasudeva
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-27       Impact factor: 2.629

10.  Quality assessment and anti-obesity activity of Stellaria media (Linn.) Vill.

Authors:  Neerja Rani; Neeru Vasudeva; Surendra Kumar Sharma
Journal:  BMC Complement Altern Med       Date:  2012-09-03       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.